Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REFA BIOMASSEINDKØB ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9%   Bankruptcy risk   13.7% 8.4% 9.6% 8.6% 12.8% 25.7% 11.6% 13.3%   Credit score (0-100)   18 31 27 28 17 2 20 3   Credit rating   B B B B B C B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   33,185 13,235 36,886 28,447 0 0 0 0   Gross profit   410 111 279 113 -59.0 -45.4 0.0 0.0   EBITDA   410 111 279 113 -59.0 -45.4 0.0 0.0   EBIT   410 111 279 113 -59.0 -45.4 0.0 0.0   Pre-tax profit (PTP)   401.8 106.2 265.1 100.6 -69.0 -50.7 0.0 0.0   Net earnings   313.4 82.9 206.8 78.5 -53.9 -39.5 0.0 0.0   Pre-tax profit without non-rec. items   402 106 265 101 -69.0 -50.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,214 972 1,096 925 871 831 751 751   Interest-bearing liabilities   238 563 0.0 390 4,780 0.0 0.0 0.0   Balance sheet total (assets)   2,796 6,719 6,387 5,507 5,660 861 751 751   Net Debt   -1,235 -812 -1,184 -1,146 3,109 -850 -751 -751     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   33,185 13,235 36,886 28,447 0 0 0 0   Net sales growth   3.2% -60.1% 178.7% -22.9% -100.0% 0.0% 0.0% 0.0%   Gross profit   410 111 279 113 -59.0 -45.4 0.0 0.0   Gross profit growth   19.9% -72.9% 151.3% -59.5% 0.0% 23.1% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,796 6,719 6,387 5,507 5,660 861 751 751   Balance sheet change%   2.3% 140.3% -4.9% -13.8% 2.8% -84.8% -12.8% 0.0%   Added value   409.6 110.9 278.7 113.0 -59.0 -45.4 0.0 0.0   Added value %   1.2% 0.8% 0.8% 0.4% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   1.0 -1.0 1.0 -1.0 -2.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   1.2% 0.8% 0.8% 0.4% 0.0% 0.0% 0.0% 0.0%   EBIT %   1.2% 0.8% 0.8% 0.4% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.9% 0.6% 0.6% 0.3% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.9% 0.6% 0.6% 0.3% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   1.2% 0.8% 0.7% 0.4% 0.0% 0.0% 0.0% 0.0%   ROA %   14.8% 2.3% 4.3% 1.9% -1.1% -1.4% 0.0% 0.0%   ROI %   31.0% 7.4% 21.2% 9.4% -1.7% -1.4% 0.0% 0.0%   ROE %   29.6% 7.6% 20.0% 7.8% -6.0% -4.6% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   43.4% 14.5% 17.2% 16.8% 15.4% 96.5% 100.0% 100.0%   Relative indebtedness %   4.8% 43.4% 14.3% 16.1% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.3% 33.0% 11.1% 10.7% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -301.6% -732.0% -424.8% -1,013.8% -5,268.8% 1,872.6% 0.0% 0.0%   Gearing %   19.6% 57.9% 0.0% 42.2% 549.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 1.2% 4.8% 6.3% 0.4% 0.2% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.9 1.2 1.2 1.2 1.2 28.7 0.0 0.0   Current Ratio   1.9 1.2 1.2 1.2 1.2 28.7 0.0 0.0   Cash and cash equivalent   1,472.9 1,374.6 1,184.1 1,535.9 1,670.5 850.1 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   13.0 142.7 52.2 53.6 58.3 241.2 0.0 0.0   Current assets / Net sales %   8.4% 50.8% 17.3% 19.4% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,302.7 972.1 1,096.1 924.6 870.7 831.2 0.0 0.0   Net working capital %   3.9% 7.3% 3.0% 3.3% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0